Risks of DaVinci Robotic-Assisted Total Hysterectomy with Bilateral Salpingo-Oophorectomy

Increased cardiovascular disease risk from premature estrogen deprivation, as noted by the American College of Obstetricians and Gynecologists, is a significant concern for women undergoing bilateral salpingo-oophorectomy before natural menopause 1, 2
Accelerated bone loss and osteoporosis risk if bilateral salpingo-oophorectomy is performed before adequate bone density is established, highlighting the need for careful consideration of the timing of such procedures 2, 3
Cognitive dysfunction risk associated with early surgical menopause, emphasizing the importance of weighing the benefits and risks of bilateral salpingo-oophorectomy in premenopausal women 1, 2
Increased all-cause mortality when oophorectomy is performed unnecessarily before natural menopause, as reported by the American College of Surgeons, underscores the need for judicious decision-making regarding the removal of ovaries 1

Mitigation Strategy for Oophorectomy Risks

Hormone replacement therapy (HRT) should be initiated immediately after surgery if the patient is not already well past menopause, and continued until at least age 51, as recommended by the North American Menopause Society, to minimize long-term health consequences 2
Estrogen-only HRT is appropriate for women who have undergone hysterectomy, as it has a more favorable safety profile than combined therapy, according to the American College of Obstetricians and Gynecologists 2
HRT minimizes long-term consequences including cardiovascular disease, osteoporosis, cognitive dysfunction, and early mortality, highlighting its importance in the management of women undergoing bilateral salpingo-oophorectomy 2

At 61 years old, the patient is likely postmenopausal, which means the hormonal consequences of oophorectomy may be less severe than in younger women, but if she is recently postmenopausal, HRT should still be strongly considered to prevent accelerated health risks, as advised by the American College of Obstetricians and Gynecologists 1, 2

Do not assume oophorectomy is risk-free at age 61 - assess the patient's menopausal status carefully and consider whether bilateral salpingo-oophorectomy is medically necessary for her indication, as emphasized by the Society of Gynecologic Oncology 1
If oophorectomy is performed and the patient is within 10 years of menopause, failing to prescribe HRT is a significant missed opportunity to prevent long-term morbidity, according to the North American Menopause Society 2
Ensure the surgical indication justifies removing both ovaries - if this is for benign disease without high-risk genetic mutations, consider whether ovarian preservation might be appropriate, as recommended by the American College of Surgeons 4, 1